Ysios news
26.10.18
Galecto Biotech Raises €79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Clinical Development
26.09.18
Minoryx Therapeutics raises €21.3M in Series B funding round
portfolio news
20.03.19
Pfizer secures exclusive option to acquire gene therapy company vivet therapeutics
27.02.19
Minoryx Therapeutics receives approval from Spanish Regulatory Agency to initiate phase 2 study in Friedreich’s Ataxia
